SCHEMBL4471140

SCHEMBL4471140

O=C(O)CCCC[n+]1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BCHE P06276 7/20 0.61
ACHE P22303 7/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5539947 0.98 BCHE (0.65) BCHEACHE
SCHEMBL5529631 0.98 BCHE (0.65) BCHEACHE
SCHEMBL5541357 0.98 BCHE (0.65) BCHEACHE
SCHEMBL5531409 0.98 BCHE (0.65) BCHEACHE
SCHEMBL5536162 0.98 BCHE (0.65) BCHEACHE
SCHEMBL5538030 0.98 BCHE (0.65) BCHEACHE
SCHEMBL5535651 0.98 BCHE (0.65) BCHEACHE
SCHEMBL5538412 0.98 BCHE (0.65) BCHEACHE
SCHEMBL5533799 0.98 BCHE (0.65) BCHEACHE
SCHEMBL5540434 0.98 BCHE (0.65) BCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115748256-A Environment-friendly impregnation system for fiber surface treatment, preparation method thereof and impregnation treatment method 北京化工大学 2023-03-07 CN disclosed
US-20190298840-A1 FORMULATIONS COMPRISING HETEROCYCLIC RING SYSTEMS AND USES THEREOF PARTICLE SCIENCES, INC. 2019-10-03 US disclosed
EP-3506948-A1 FORMULATIONS COMPRISING HETEROCYCLIC RING SYSTEMS AND USES THEREOF Particle Sciences, Inc. (US) 2019-07-10 EP disclosed
WO-2018045077-A1 FORMULATIONS COMPRISING HETEROCYCLIC RING SYSTEMS AND USES THEREOF PARTICLE SCIENCES, INC. (US) 2018-03-08 WO disclosed
US-7625917-B2 S-o-(phenylaminocarbonyl)phenyl-substituted, especially with a quaternary onium group; enhanced antiviral activity and better reactivity with zinc finger moieties, particularly, the zinc finger on HIV-1's NCp7 nucleocapsid protein TURPIN JAMES A 2009-12-01 US disclosed
US-7625917-B2 S-o-(phenylaminocarbonyl)phenyl-substituted, especially with a quaternary onium group; enhanced antiviral activity and better reactivity with zinc finger moieties, particularly, the zinc finger on HIV-1's NCp7 nucleocapsid protein TURPIN JAMES A 2009-12-01 US disclosed
EP-1087941-B9 THIOLESTERS AND USES THEREOF US HEALTH (US) 2007-11-07 EP disclosed
US-20070044831-A1 Electrolyte composition and dye-sensitized solar cell NATIONAL UNIVERSITY CORPORATION KYUSHU INSTITUTE OF TECHNOLOGY (JP) 2007-03-01 US disclosed
EP-1087941-B1 THIOLESTERS AND USES THEREOF US HEALTH (US) 2006-08-16 EP disclosed
US-20040132785-A1 Thiolesters and uses thereof The Government of the U. S.of America as Represented by The Sec. of Health and Human Svc. (US) 2004-07-08 US disclosed
US-6706729-B1 A METHOD FOR DISSOCIATING A METAL ION FROM A ZINC FINGER-CONTAINING PROTEIN; INHIBITING VIRUS THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES 2004-03-16 US disclosed
EP-1087941-A2 THIOLESTERS AND USES THEREOF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, Department of Health and Human Services (US) 2001-04-04 EP disclosed
WO-1999065871-A2 THIOLESTERS AND USES THEREOF THE GOVERNMENT OF THE UNITED STATES OF AMERICA REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1999-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040132785-A1 Thiolesters and uses thereof SARS1, HAVCR2, P4HB BCHE 1246/4885ACHE 2225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.